| Stage | UHAL | % of rev | NRDS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.7B | 100.00% | $197M | 100.00% | UHAL ×8.53 |
| Gross profit | $1.7B | 100.00% | $184M | 93.21% | UHAL +6.8pp |
| Operating income | $251M | 14.90% | $7M | 3.55% | UHAL +11.4pp |
| Pre-tax income | $162M | 9.61% | $7M | 3.70% | UHAL +5.9pp |
| Net income | $123M | 7.31% | $4M | 2.18% | UHAL +5.1pp |
| Stage | UHAL | NRDS | Gap · A − B |
|---|---|---|---|
| Revenue | $1.7B100.00% | $197M100.00% | UHAL ×8.53 |
| Gross profit | 100.00%$1.7B | 93.21%$184M | UHAL +6.8pp |
| Operating income | 14.90%$251M | 3.55%$7M | UHAL +11.4pp |
| Pre-tax income | 9.61%$162M | 3.70%$7M | UHAL +5.9pp |
| Net income |
| 7.31%$123M |
| 2.18%$4M |
| UHAL +5.1pp |
No disclosed counterparties: NRDS.
None